Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime

被引：12

作者：

Alyaseen, SA

Piper, KE

Rouse, MS

Steckelberg, JM

Patel, R

机构：

[1] Mayo Clin, Coll Med, Div Infect Dis, Dept Internal Med, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 06期

关键词：

D O I：

10.1128/AAC.49.6.2543-2545.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.

引用

收藏

页码：2543 / 2545

页数：3

相关论文

共 10 条

[1] Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999:: Role of target enzyme in mechanism of fluoroquinolone resistance [J].

Akasaka, T ;

Tanaka, M ;

Yamaguchi, A ;

Sato, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2263-2268

[2]

[Anonymous], M07A6 NCCLS

[3] Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].

Fung-Tomc, JC ;

Minassian, B ;

Kolek, B ;

Huczko, E ;

Aleksunes, L ;

Stickle, T ;

Washo, T ;

Gradelski, E ;

Valera, L ;

Bonner, DP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356

[4]

Lee YS, 2000, ELEC SOC S, V2000, P182

[5] A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa [J].

Li, Y ;

Mima, T ;

Komori, Y ;

Morita, Y ;

Kuroda, T ;

Mizushima, T ;

Tsuchiya, T .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :572-575

[6] Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa [J].

Lomovskaya, O ;

Lee, A ;

Hoshino, K ;

Ishida, H ;

Mistry, A ;

Warren, MS ;

Boyer, E ;

Chamberland, S ;

Lee, VJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1340-1346

[7] Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa [J].

Maseda, H ;

Yoneyama, H ;

Nakae, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :658-664

[8] Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units:: Role of antibiotics with antipseudomonal activity [J].

Paramythiotou, E ;

Lucet, JC ;

Timsit, JF ;

Vanjak, D ;

Paugam-Burtz, C ;

Trouillet, JL ;

Belloc, S ;

Kassis, N ;

Karabinis, A ;

Andremont, A .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :670-677

[9] Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates [J].

Patel, R ;

Piper, KE ;

Rouse, MS ;

Steckelberg, JM ;

Uhl, JR ;

Kohner, P ;

Hopkins, MK ;

Cockerill, FR ;

Kline, BC .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) :3399-3407

[10] Pseudomonas aeruginosa ventilator-associated pneumonia:: Comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms [J].

Trouillet, JL ;

Vuagnat, A ;

Combes, A ;

Kassis, N ;

Chastre, J ;

Gibert, C .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1047-1054